JAK2 and idiopathic pulmonary fibrosis: Of note, the responses to JSI-124 were reduced in IPF and IPP + PH PCLS compared to controls, suggesting that JAK2, a non-receptor tyrosine kinase activated by a broad spectrum of vasoactive mediators, might be upregulated in disease (Milara et al., 2018).